Researchers across Mass General Brigham hospitals support a multitude of cancer programs that explore cancer at the molecular, cellular, tissue, and whole-organism levels to advance the treatment and prevention of human disease.
Some of the key areas at Mass General Brigham include state-of-the-art and emerging approaches to diagnose, treat and manage cancer—including early cancer detection and prevention; precision medicine and evolving models of care; immunological therapies; combination therapies to circumvent resistance; methods to find and develop new targets and new drugs as well as new informatics-driven tools and research approaches
In addition, this sector works with the Pathology departments to explore the diagnosis and pathogenesis of disease, with a focus on cancer-related fields. Computational Pathology continues to be a primary focus at both hospitals. Industry collaborations across these fields are focused on drug discovery, stem cell research, and digital pathology, among others.
Departments and Centers
Brigham and Women's Hospital
BWH Department of Pathology
Informatics for Integrating Biology & the Bedside (i2b2)
Massachusetts General Hospital
MGH Cancer Center and the Center for Cancer Research
Center for Cancer Risk Assessment
Center for Molecular Therapeutics
Center for Regenerative Medicine
Circulating Tumor Cell Center
Center for Computational Discovery
MGH Tissue Repository
Molecular Profiling Laboratory
MGH Pathology
Specialized Histopathology Core